Your Article Summary
Renal neuroendocrine tumors
Indian Journal of Urology, 06/25/09
Lane BR et al. - A spectrum of NETs can rarely occur in the kidney. Renal carcinoids have a variable clinical course; SCC and LCNEC are associated with poor clinical outcomes. Diagnosis of NETs, especially LCNEC, requires awareness of their rare occurrence and prudent use of immunohistochemical neuroendocrine markers.
Related Articles
Miscellaneous Cancers (Lung, Thyroid, Renal Cancer, Myeloma, and Neuroendocrine Tumors): Role of SPECT and PET in Imaging Bone Metastases
Seminars in Nuclear Medicine, 10/14/09
Relevance Score: 67%
High-dose Octreotide Acetate for Management of Gastroenteropancreatic Neuroendocrine Tumors
Anticancer Research, 11/11/09
Relevance Score: 66%
Continuous 5-fluorouracil infusion plus long acting Octreotide in advanced well differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network.
BMC Cancer, 11/09/09
Relevance Score: 66%
Liver Metastases of Neuroendocrine Tumors: Treatment With Hepatic Transarterial Chemotherapy Using Two Therapeutic Protocols
American Journal of Roentgenology, 10/08/09
Relevance Score: 66%
Targeting the mTOR Pathway in Neuroendocrine Tumors
Clinical Journal of Oncology Nursing, 10/07/09
Relevance Score: 65%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pilot Study: Association of Traditional and Genetic Risk Factors and New-Onset Diabetes Mellitus Following Kidney Transplantation
Transplantation Proceedings, 12/18/09
Relation Between Thyroid Hormones and Insulin Resistance in Hemodialysis Patients
Kidney, 12/18/09
Increased Urinary Angiotensinogen Is Precedent to Increased Urinary Albumin in Patients With Type 1 Diabetes
The American Journal of the Medical Sciences, 12/17/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, 12/18/09
Renal cell carcinoma with caval involvement: Contemporary strategies of surgical treatment
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells
Urologic Oncology: Seminars and Original Investigations, 12/18/09

See Latest Articles